Gene · 9846
Papers1,533
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,533
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Different tumorigenicity and distinct metastasis and gene signature between orthotopic and subcutaneous neuroblastoma xenografted mice. | Aging (Albany NY) | 2022 | 35197367 | PubTator, text mining | PubMed |
| HOXA-AS2 contributes to regulatory T cell proliferation and immune tolerance in glioma through the miR-302a/KDM2A/JAG1 axis. | Cell Death Dis | 2022 | 35181676 | PubTator, text mining | PubMed |
| FOXD3 and GAB2 as a pair of rivals antagonistically control hepatocellular carcinogenesis. | FEBS J | 2022 | 35178865 | PubTator, text mining | PubMed |
| Intrinsically disordered proteins play diverse roles in cell signaling. | Cell Commun Signal | 2022 | 35177069 | PubTator, text mining | PubMed |
| Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View. | Int J Mol Sci | 2022 | 35163222 | PubTator, text mining | PubMed |
| Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma. | Int J Mol Sci | 2022 | 35163019 | PubTator, text mining | PubMed |
| Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer. | Cancers (Basel) | 2022 | 35158858 | PubTator, text mining | PubMed |
| Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma. | PeerJ | 2022 | 35116193 | PubTator, text mining | PubMed |
| DNA methylation changes in glial cells of the normal-appearing white matter in Multiple Sclerosis patients. | Epigenetics | 2022 | 35094644 | PubTator, text mining | PubMed |
| [Retracted] MicroRNA‑485 plays tumour‑suppressive roles in colorectal cancer by directly targeting GAB2. | Oncol Rep | 2022 | 35088894 | PubTator, text mining | PubMed |
| The biomarkers of key miRNAs and gene targets associated with extranodal NK/T-cell lymphoma. | Open Med (Wars) | 2022 | 35071774 | PubTator, text mining | PubMed |
| SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia. | Blood Adv | 2022 | 35061886 | PubTator, text mining | PubMed |
| BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia. | Pharmaceutics | 2022 | 35057108 | PubTator, text mining | PubMed |
| Core promoter mutation contributes to abnormal gene expression in bladder cancer. | BMC Cancer | 2022 | 35033028 | PubTator, text mining | PubMed |
| Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration. | Mol Cancer Res | 2022 | 35022314 | PubTator, text mining | PubMed |
| Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy. | Cells | 2022 | 35011736 | PubTator, text mining | PubMed |
| Co-Expression Analysis of microRNAs and Proteins in Brain of Alzheimer's Disease Patients. | Cells | 2022 | 35011725 | PubTator, text mining | PubMed |
| Temporal Quantitative Phosphoproteomics Profiling of Interleukin-33 Signaling Network Reveals Unique Modulators of Monocyte Activation. | Cells | 2022 | 35011700 | PubTator, text mining | PubMed |
| Comprehensive analysis of the exocytosis pathway genes in cervical cancer. | Am J Med Sci | 2022 | 34995576 | PubTator, text mining | PubMed |
| Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment. | HGG Adv | 2022 | 34993496 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9846/papers?page=15